3Washington AE, Katz P. Cost of and payment source for pelvic inflammatory disease. Trends and projections, 1983 through 2000. JAMA, 1991,266:2565-2569.
4Sylvan SP, Von Krogh G, Tiveljung A, et al. Screening and genotyping of genital Chlamydia trachomatis in urine specimens from male and female clients of youth-health centers in Stockholm County. Sex Transm Dis,2002,29:379-386.
5Sturm-Ramirez K, Brumblay H, Diop K, et al. Molecular epidemiology of genital Chlamydia trachomatis infection in high- risk women in Senegal, West Africa. J Clin Microbiol,2000,38: 138-145.
6Mardh PA, Novikova N. Chlamydia trachomatis infectionsa major concer for reproductive health. Where do we stand regarding epidemiology, pathogenesis, diagnosis and therapy [J]. Eur J Contracept Reprod Health Care,2001,6(2): 115- 126.
7Puolakkainen M, Hiltuen BE, Reunala T, et al. Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction tests , in detection of urogenital chlamydia trachomatis infection [J]. J Clin Microbiol, 1998,36(6): 1489.
